359 related articles for article (PubMed ID: 6353526)
1. Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.
Sanders CC; Sanders WE
Rev Infect Dis; 1983; 5(4):639-48. PubMed ID: 6353526
[TBL] [Abstract][Full Text] [Related]
2. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.
Sanders CC; Sanders WE
J Infect Dis; 1985 Mar; 151(3):399-406. PubMed ID: 2982957
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of inducible beta-lactamases in gram-negative bacteria.
Sanders CC; Sanders WE
Eur J Clin Microbiol; 1987 Aug; 6(4):435-8. PubMed ID: 3311737
[TBL] [Abstract][Full Text] [Related]
4. Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.
Werner V; Sanders CC; Sanders WE; Goering RV
Antimicrob Agents Chemother; 1985 Apr; 27(4):455-9. PubMed ID: 3873897
[TBL] [Abstract][Full Text] [Related]
5. [Bacterial resistance against beta-lactam antibiotics].
Andersen BM
Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
[TBL] [Abstract][Full Text] [Related]
6. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa.
Aronoff SC
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
Pitout JD; Sanders CC; Sanders WE
Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
Kotra LP; Mobashery S
Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
11. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
Pechère JC
Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.
Steffee CH; Wasilauskas BL
Chemotherapy; 1992; 38(5):291-6. PubMed ID: 1286572
[TBL] [Abstract][Full Text] [Related]
13. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
Neu HC
Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
[TBL] [Abstract][Full Text] [Related]
14. Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain.
Colom K; Fdz-Aranguiz A; Suinaga E; Cisterna R
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):964-71. PubMed ID: 8654447
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
Szabó D; Barcs I; Rozgonyi F
Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
[TBL] [Abstract][Full Text] [Related]
16. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
Lerner SA; Quinn JP
Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
[TBL] [Abstract][Full Text] [Related]
17. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
Schito GC; Pesce A; Debbia EA
Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
[TBL] [Abstract][Full Text] [Related]
18. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
Jones RN
Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
[TBL] [Abstract][Full Text] [Related]
19. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
Semenitz E
Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
